More issues

Renewing Brineura (Cerliponase Alfa) Approval with Cigna in Virginia: 2025 Guide to Documentation, Timelines, and Appeals

Answer Box: Renewing Your Brineura Coverage with Cigna in Virginia Cigna typically authorizes Brineura (cerliponase alfa) for 6-month periods and requires comprehensive renewal documentation including updated clinical notes, device status reports, and evidence of ongoing benefit. Start your renewal application 30-60 days before expiration to avoid therapy gaps. Required documents
6 min read

Getting Mepsevii (Vestronidase Alfa) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval To get Mepsevii (vestronidase alfa-vjbk) covered by UnitedHealthcare in New Jersey: Submit prior authorization through OptumRx with complete MPS VII diagnostic proof (enzyme assay, genetic testing, elevated uGAGs) from a metabolic specialist. If denied, file internal appeal within 180 days, then external review through
7 min read

How to Get Vyondys 53 (Golodirsen) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Vyondys 53 Covered by Aetna CVS Health in Illinois Fastest path to approval: Submit prior authorization with genetic testing confirming exon 53 mutation, baseline kidney function labs, and neuromuscular specialist oversight. If denied, request peer-to-peer review within days, then file internal appeal within 180 days. Illinois residents
6 min read

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Billing Codes

Answer Box: Getting Besponsa Covered by Humana in North Carolina Besponsa (inotuzumab ozogamicin) requires prior authorization through Evolent/New Century Health for all Humana Medicare Advantage plans. Submit requests via their portal at my.newcenturyhealth.com or call 844-926-4528 (option 5). Required documentation includes CD22-positive B-cell ALL diagnosis (ICD-10: C91.
6 min read

Work With Your Doctor to Get Luxturna (Voretigene Neparvovec-rzyl) Approved by Blue Cross Blue Shield in Ohio: Complete Provider Collaboration Guide

Answer Box: Getting Luxturna Approved in Ohio Luxturna (voretigene neparvovec-rzyl) requires prior authorization from Blue Cross Blue Shield in Ohio, with strict criteria including confirmed biallelic RPE65 mutations and viable retinal cells. The fastest path: 1) Get genetic testing confirming RPE65 mutations, 2) Schedule comprehensive retinal assessment at a qualified
5 min read